The ESMO Preceptorship on Neuroendocrine Neoplasms (NENs) 2026 is a specialized educational meeting scheduled to take place from June 10–11, 2026, in Hong Kong SAR, China. Co-chaired by Nicola Fazio and David Tai, this course is designed to provide oncology professionals with a thorough grounding in the multidisciplinary management of neuroendocrine tumors, ranging from diagnosis to advanced therapeutic strategies.

The program typically emphasizes the integration of clinical guidelines into practical patient care, covering the latest developments in pathology, imaging, and systemic treatments, including peptide receptor radionuclide therapy (PRRT). Through expert-led lectures and clinical case discussions, the preceptorship aims to enhance the clinical expertise of participants and foster international collaboration in the field of rare tumor management.

Application.